ZA200300719B - Compounds and methods for treatment and diagnosis of Chlamydial infection. - Google Patents

Info

Publication number

ZA200300719B

ZA200300719B ZA200300719A ZA200300719A ZA200300719B ZA 200300719 B ZA200300719 B ZA 200300719B ZA 200300719 A ZA200300719 A ZA 200300719A ZA 200300719 A ZA200300719 A ZA 200300719A ZA 200300719 B ZA200300719 B ZA 200300719B

Authority

ZA

South Africa

Prior art keywords

seq

chlamydia

sequence

composition

protein

Prior art date

2000-07-20

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims description 159
• 238000011282 treatment Methods 0.000 title claims description 33
• 206010061041 Chlamydial infection Diseases 0.000 title description 22
• 201000000902 chlamydia Diseases 0.000 title description 21
• 208000012538 chlamydia trachomatis infectious disease Diseases 0.000 title description 21
• 150000001875 compounds Chemical class 0.000 title description 17
• 238000003745 diagnosis Methods 0.000 title description 4
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 418
• 108090000623 proteins and genes Proteins 0.000 claims description 341
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 320
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 288
• 229920001184 polypeptide Polymers 0.000 claims description 261
• 102000004169 proteins and genes Human genes 0.000 claims description 162
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 142
• 102000040430 polynucleotide Human genes 0.000 claims description 136
• 108091033319 polynucleotide Proteins 0.000 claims description 136
• 239000002157 polynucleotide Substances 0.000 claims description 136
• 210000004027 cell Anatomy 0.000 claims description 133
• 239000000427 antigen Substances 0.000 claims description 126
• 108091007433 antigens Proteins 0.000 claims description 126
• 102000036639 antigens Human genes 0.000 claims description 126
• 241000606161 Chlamydia Species 0.000 claims description 112
• 239000000203 mixture Substances 0.000 claims description 89
• 239000013598 vector Substances 0.000 claims description 86
• 230000002163 immunogen Effects 0.000 claims description 73
• 102000037865 fusion proteins Human genes 0.000 claims description 70
• 108020001507 fusion proteins Proteins 0.000 claims description 70
• 239000012634 fragment Substances 0.000 claims description 67
• 230000014509 gene expression Effects 0.000 claims description 62
• 239000000126 substance Substances 0.000 claims description 55
• 150000001413 amino acids Chemical class 0.000 claims description 53
• 239000000523 sample Substances 0.000 claims description 43
• 239000013604 expression vector Substances 0.000 claims description 41
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 33
• 241001465754 Metazoa Species 0.000 claims description 29
• 230000003308 immunostimulating effect Effects 0.000 claims description 29
• 229960001438 immunostimulant agent Drugs 0.000 claims description 28
• 239000003022 immunostimulating agent Substances 0.000 claims description 28
• 230000027455 binding Effects 0.000 claims description 26
• 238000004519 manufacturing process Methods 0.000 claims description 26
• 230000028993 immune response Effects 0.000 claims description 25
• 239000003153 chemical reaction reagent Substances 0.000 claims description 24
• 238000001514 detection method Methods 0.000 claims description 23
• 230000004936 stimulating effect Effects 0.000 claims description 22
• 208000007190 Chlamydia Infections Diseases 0.000 claims description 21
• 238000002360 preparation method Methods 0.000 claims description 20
• 239000012472 biological sample Substances 0.000 claims description 19
• 108091034117 Oligonucleotide Proteins 0.000 claims description 18
• 239000011230 binding agent Substances 0.000 claims description 17
• 125000006853 reporter group Chemical group 0.000 claims description 15
• 230000003612 virological effect Effects 0.000 claims description 14
• 101150077194 CAP1 gene Proteins 0.000 claims description 13
• 230000005867 T cell response Effects 0.000 claims description 13
• 101100245221 Mus musculus Prss8 gene Proteins 0.000 claims description 12
• 239000000969 carrier Substances 0.000 claims description 10
• 238000011161 development Methods 0.000 claims description 10
• 230000000638 stimulation Effects 0.000 claims description 9
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 8
• 230000002401 inhibitory effect Effects 0.000 claims description 8
• 241000700618 Vaccinia virus Species 0.000 claims description 7
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 claims description 4
• 238000009007 Diagnostic Kit Methods 0.000 claims description 4
• 206010028980 Neoplasm Diseases 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 241000606153 Chlamydia trachomatis Species 0.000 description 536
• 108091028043 Nucleic acid sequence Proteins 0.000 description 333
• 229940038705 chlamydia trachomatis Drugs 0.000 description 120
• 235000018102 proteins Nutrition 0.000 description 115
• 239000013615 primer Substances 0.000 description 101
• 108700026244 Open Reading Frames Proteins 0.000 description 99
• 241001647372 Chlamydia pneumoniae Species 0.000 description 88
• 239000013256 coordination polymer Substances 0.000 description 71
• 108020004414 DNA Proteins 0.000 description 51
• 229960005486 vaccine Drugs 0.000 description 48
• 238000010367 cloning Methods 0.000 description 46
• 235000001014 amino acid Nutrition 0.000 description 43
• 229940024606 amino acid Drugs 0.000 description 41
• 210000004443 dendritic cell Anatomy 0.000 description 41
• 239000002773 nucleotide Substances 0.000 description 37
• 125000003729 nucleotide group Chemical group 0.000 description 37
• 102100035954 Choline transporter-like protein 2 Human genes 0.000 description 33
• 101000948115 Homo sapiens Choline transporter-like protein 2 Proteins 0.000 description 33
• 238000003556 assay Methods 0.000 description 32
• 230000015572 biosynthetic process Effects 0.000 description 32
• 238000003786 synthesis reaction Methods 0.000 description 32
• 208000015181 infectious disease Diseases 0.000 description 30
• 238000003752 polymerase chain reaction Methods 0.000 description 30
• 241000498849 Chlamydiales Species 0.000 description 29
• 239000002671 adjuvant Substances 0.000 description 27
• 206010035664 Pneumonia Diseases 0.000 description 25
• 230000004927 fusion Effects 0.000 description 25
• 101150106828 pmpD gene Proteins 0.000 description 24
• 230000004044 response Effects 0.000 description 24
• 238000002965 ELISA Methods 0.000 description 23
• 125000005647 linker group Chemical group 0.000 description 23
• 230000036961 partial effect Effects 0.000 description 23
• 101000956368 Trittame loki CRISP/Allergen/PR-1 Proteins 0.000 description 22
• 101150061263 tct-1 gene Proteins 0.000 description 22
• 230000000692 anti-sense effect Effects 0.000 description 21
• 239000002299 complementary DNA Substances 0.000 description 20
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 20
• 239000002953 phosphate buffered saline Substances 0.000 description 20
• 101150050161 pmpC gene Proteins 0.000 description 20
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 19
• 239000003795 chemical substances by application Substances 0.000 description 19
• 239000008194 pharmaceutical composition Substances 0.000 description 19
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 18
• 230000009696 proliferative response Effects 0.000 description 18
• 239000007787 solid Substances 0.000 description 17
• 108010076504 Protein Sorting Signals Proteins 0.000 description 16
• 210000001616 monocyte Anatomy 0.000 description 16
• 101150059608 pmpE gene Proteins 0.000 description 16
• 239000012528 membrane Substances 0.000 description 15
• 102000004127 Cytokines Human genes 0.000 description 14
• 108090000695 Cytokines Proteins 0.000 description 14
• 241000699670 Mus sp. Species 0.000 description 14
• 230000003053 immunization Effects 0.000 description 14
• 238000002649 immunization Methods 0.000 description 14
• 210000004379 membrane Anatomy 0.000 description 14
• 101150053615 pmpG gene Proteins 0.000 description 14
• 210000002966 serum Anatomy 0.000 description 14
• 210000004899 c-terminal region Anatomy 0.000 description 13
• 230000001900 immune effect Effects 0.000 description 13
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 13
• 102100034763 Peroxiredoxin-2 Human genes 0.000 description 12
• 241000700605 Viruses Species 0.000 description 12
• 239000012636 effector Substances 0.000 description 12
• 238000001727 in vivo Methods 0.000 description 12
• 102000009016 Cholera Toxin Human genes 0.000 description 11
• 108010049048 Cholera Toxin Proteins 0.000 description 11
• 241000588724 Escherichia coli Species 0.000 description 11
• 238000007792 addition Methods 0.000 description 11
• 230000003321 amplification Effects 0.000 description 11
• 238000009472 formulation Methods 0.000 description 11
• 230000006698 induction Effects 0.000 description 11
• 239000002609 medium Substances 0.000 description 11
• 238000003199 nucleic acid amplification method Methods 0.000 description 11
• 238000000746 purification Methods 0.000 description 11
• 230000009257 reactivity Effects 0.000 description 11
• 210000004989 spleen cell Anatomy 0.000 description 11
• 238000004458 analytical method Methods 0.000 description 10
• 230000000295 complement effect Effects 0.000 description 10
• 238000012217 deletion Methods 0.000 description 10
• 230000037430 deletion Effects 0.000 description 10
• 239000003814 drug Substances 0.000 description 10
• 238000011534 incubation Methods 0.000 description 10
• 150000007523 nucleic acids Chemical class 0.000 description 10
• 101150067195 pmpB gene Proteins 0.000 description 10
• 230000001177 retroviral effect Effects 0.000 description 10
• 238000006467 substitution reaction Methods 0.000 description 10
• 102000053602 DNA Human genes 0.000 description 9
• 101100462201 Mus musculus Opn4 gene Proteins 0.000 description 9
• 241000283973 Oryctolagus cuniculus Species 0.000 description 9
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 9
• 125000000539 amino acid group Chemical group 0.000 description 9
• 230000001580 bacterial effect Effects 0.000 description 9
• 230000009089 cytolysis Effects 0.000 description 9
• 238000009169 immunotherapy Methods 0.000 description 9
• 239000000047 product Substances 0.000 description 9
• 230000035755 proliferation Effects 0.000 description 9
• 238000010561 standard procedure Methods 0.000 description 9
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
• 108091081024 Start codon Proteins 0.000 description 8
• 210000004369 blood Anatomy 0.000 description 8
• 239000008280 blood Substances 0.000 description 8
• 238000002474 experimental method Methods 0.000 description 8
• 238000000338 in vitro Methods 0.000 description 8
• 239000004005 microsphere Substances 0.000 description 8
• 102000039446 nucleic acids Human genes 0.000 description 8
• 108020004707 nucleic acids Proteins 0.000 description 8
• 230000001681 protective effect Effects 0.000 description 8
• -1 rRNA Proteins 0.000 description 8
• 230000002441 reversible effect Effects 0.000 description 8
• 238000012216 screening Methods 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 7
• 239000003155 DNA primer Substances 0.000 description 7
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 7
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 7
• 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 7
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 7
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 7
• 101710183681 Uncharacterized protein 7 Proteins 0.000 description 7
• 239000011651 chromium Substances 0.000 description 7
• 230000005847 immunogenicity Effects 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 210000004962 mammalian cell Anatomy 0.000 description 7
• 238000013507 mapping Methods 0.000 description 7
• 239000013612 plasmid Substances 0.000 description 7
• 238000012360 testing method Methods 0.000 description 7
• 238000011144 upstream manufacturing Methods 0.000 description 7
• 101100438368 Caenorhabditis elegans cap-1 gene Proteins 0.000 description 6
• 201000005019 Chlamydia pneumonia Diseases 0.000 description 6
• 108020004705 Codon Proteins 0.000 description 6
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
• 230000006052 T cell proliferation Effects 0.000 description 6
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
• 238000001042 affinity chromatography Methods 0.000 description 6
• 239000011324 bead Substances 0.000 description 6
• 201000010099 disease Diseases 0.000 description 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
• 230000000694 effects Effects 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 239000002502 liposome Substances 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 239000013642 negative control Substances 0.000 description 6
• 239000002751 oligonucleotide probe Substances 0.000 description 6
• 208000030773 pneumonia caused by chlamydia Diseases 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 210000004988 splenocyte Anatomy 0.000 description 6
• 230000014616 translation Effects 0.000 description 6
• 238000013519 translation Methods 0.000 description 6
• 241000701161 unidentified adenovirus Species 0.000 description 6
• 101100494773 Caenorhabditis elegans ctl-2 gene Proteins 0.000 description 5
• 108091026890 Coding region Proteins 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 241000713673 Human foamy virus Species 0.000 description 5
• 241000714177 Murine leukemia virus Species 0.000 description 5
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 5
• 238000012408 PCR amplification Methods 0.000 description 5
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 230000000890 antigenic effect Effects 0.000 description 5
• 238000013459 approach Methods 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 238000002405 diagnostic procedure Methods 0.000 description 5
• 238000010790 dilution Methods 0.000 description 5
• 239000012895 dilution Substances 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 230000028996 humoral immune response Effects 0.000 description 5
• 238000003018 immunoassay Methods 0.000 description 5
• 229940127121 immunoconjugate Drugs 0.000 description 5
• 230000002458 infectious effect Effects 0.000 description 5
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
• 239000011159 matrix material Substances 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 108030002458 peroxiredoxin Proteins 0.000 description 5
• 238000007920 subcutaneous administration Methods 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• 230000001225 therapeutic effect Effects 0.000 description 5
• 238000001890 transfection Methods 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 241000023308 Acca Species 0.000 description 4
• 108700028369 Alleles Proteins 0.000 description 4
• 101100130895 Bacillus subtilis (strain 168) mntA gene Proteins 0.000 description 4
• 238000011735 C3H mouse Methods 0.000 description 4
• 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 4
• 101100087840 Dictyostelium discoideum rnrB-2 gene Proteins 0.000 description 4
• 108091060211 Expressed sequence tag Proteins 0.000 description 4
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
• 108010002350 Interleukin-2 Proteins 0.000 description 4
• 102000000588 Interleukin-2 Human genes 0.000 description 4
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
• 101710149059 Large cysteine-rich periplasmic protein OmcB Proteins 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 4
• 101710197985 Probable protein Rev Proteins 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• 108090000792 Ribosomal protein L1 Proteins 0.000 description 4
• 101100428373 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) POR1 gene Proteins 0.000 description 4
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
• 101100443856 Streptococcus pyogenes serotype M18 (strain MGAS8232) polC gene Proteins 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
• 229960003767 alanine Drugs 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 210000003719 b-lymphocyte Anatomy 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 230000001186 cumulative effect Effects 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 230000003292 diminished effect Effects 0.000 description 4
• 101150008507 dnaE gene Proteins 0.000 description 4
• 101150035285 dnaE1 gene Proteins 0.000 description 4
• 101150003155 dnaG gene Proteins 0.000 description 4
• 101150052825 dnaK gene Proteins 0.000 description 4
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 4
• 235000013861 fat-free Nutrition 0.000 description 4
• 101150008469 flhA gene Proteins 0.000 description 4
• 150000004676 glycans Chemical class 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 230000036039 immunity Effects 0.000 description 4
• 230000001976 improved effect Effects 0.000 description 4
• 101150077178 infC gene Proteins 0.000 description 4
• 210000002540 macrophage Anatomy 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 229940035032 monophosphoryl lipid a Drugs 0.000 description 4
• 101150067482 msbA gene Proteins 0.000 description 4
• 238000002703 mutagenesis Methods 0.000 description 4
• 231100000350 mutagenesis Toxicity 0.000 description 4
• 101150037566 nrdB gene Proteins 0.000 description 4
• 101150087557 omcB gene Proteins 0.000 description 4
• 210000005259 peripheral blood Anatomy 0.000 description 4
• 239000011886 peripheral blood Substances 0.000 description 4
• 229920001282 polysaccharide Polymers 0.000 description 4
• 239000005017 polysaccharide Substances 0.000 description 4
• 235000008476 powdered milk Nutrition 0.000 description 4
• 239000002987 primer (paints) Substances 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108091008146 restriction endonucleases Proteins 0.000 description 4
• 238000012552 review Methods 0.000 description 4
• 210000003705 ribosome Anatomy 0.000 description 4
• 150000003839 salts Chemical class 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 101150111539 ytgA gene Proteins 0.000 description 4
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• 229920000936 Agarose Polymers 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 241001185363 Chlamydiae Species 0.000 description 3
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
• 241000759568 Corixa Species 0.000 description 3
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
• 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 3
• 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 3
• 238000011510 Elispot assay Methods 0.000 description 3
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• 241000725303 Human immunodeficiency virus Species 0.000 description 3
• 108060003951 Immunoglobulin Proteins 0.000 description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
• 102100034349 Integrase Human genes 0.000 description 3
• 108090000978 Interleukin-4 Proteins 0.000 description 3
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 3
• 108091092195 Intron Proteins 0.000 description 3
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 229930195725 Mannitol Natural products 0.000 description 3
• 108010052285 Membrane Proteins Proteins 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 206010035673 Pneumonia chlamydial Diseases 0.000 description 3
• 206010036790 Productive cough Diseases 0.000 description 3
• 101710188053 Protein D Proteins 0.000 description 3
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 208000007313 Reproductive Tract Infections Diseases 0.000 description 3
• 101710132893 Resolvase Proteins 0.000 description 3
• 102000002278 Ribosomal Proteins Human genes 0.000 description 3
• 108010000605 Ribosomal Proteins Proteins 0.000 description 3
• 241000714474 Rous sarcoma virus Species 0.000 description 3
• 229920002472 Starch Polymers 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 108700012920 TNF Proteins 0.000 description 3
• 101150109085 TSA gene Proteins 0.000 description 3
• 206010046865 Vaccinia virus infection Diseases 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 229940098773 bovine serum albumin Drugs 0.000 description 3
• 239000001913 cellulose Substances 0.000 description 3
• 229920002678 cellulose Polymers 0.000 description 3
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
• 238000012512 characterization method Methods 0.000 description 3
• 229910052804 chromium Inorganic materials 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 239000012228 culture supernatant Substances 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 238000001400 expression cloning Methods 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 102000018358 immunoglobulin Human genes 0.000 description 3
• 238000002513 implantation Methods 0.000 description 3
• 238000011065 in-situ storage Methods 0.000 description 3
• 230000001965 increasing effect Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 235000010355 mannitol Nutrition 0.000 description 3
• 239000000594 mannitol Substances 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 101150106833 metG gene Proteins 0.000 description 3
• 101150062025 metG1 gene Proteins 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 201000000050 myeloid neoplasm Diseases 0.000 description 3
• 210000002381 plasma Anatomy 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 235000019419 proteases Nutrition 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 230000035945 sensitivity Effects 0.000 description 3
• 239000000243 solution Substances 0.000 description 3
• 238000001179 sorption measurement Methods 0.000 description 3
• 210000003802 sputum Anatomy 0.000 description 3
• 208000024794 sputum Diseases 0.000 description 3
• 239000008107 starch Substances 0.000 description 3
• 235000019698 starch Nutrition 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 239000003053 toxin Substances 0.000 description 3
• 231100000765 toxin Toxicity 0.000 description 3
• 108700012359 toxins Proteins 0.000 description 3
• 241001430294 unidentified retrovirus Species 0.000 description 3
• 210000002700 urine Anatomy 0.000 description 3
• 208000007089 vaccinia Diseases 0.000 description 3
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
• 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 2
• 101000787132 Acidithiobacillus ferridurans Uncharacterized 8.2 kDa protein in mobL 3'region Proteins 0.000 description 2
• 101000827262 Acidithiobacillus ferrooxidans Uncharacterized 18.9 kDa protein in mobE 3'region Proteins 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 108700023418 Amidases Proteins 0.000 description 2
• 108091093088 Amplicon Proteins 0.000 description 2
• 108020005544 Antisense RNA Proteins 0.000 description 2
• 101000811747 Antithamnion sp. UPF0051 protein in atpA 3'region Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 101000827607 Bacillus phage SPP1 Uncharacterized 8.5 kDa protein in GP2-GP6 intergenic region Proteins 0.000 description 2
• 101100087825 Bacillus subtilis (strain 168) nrdE gene Proteins 0.000 description 2
• 101000961975 Bacillus thuringiensis Uncharacterized 13.4 kDa protein Proteins 0.000 description 2
• 101000653197 Beet necrotic yellow vein virus (isolate Japan/S) Movement protein TGB3 Proteins 0.000 description 2
• 101000609456 Beet necrotic yellow vein virus (isolate Japan/S) Protein P26 Proteins 0.000 description 2
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
• 101150013553 CD40 gene Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 101000964407 Caldicellulosiruptor saccharolyticus Uncharacterized 10.7 kDa protein in xynB 3'region Proteins 0.000 description 2
• 108010058432 Chaperonin 60 Proteins 0.000 description 2
• 241001227713 Chiron Species 0.000 description 2
• ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
• 241000557626 Corvus corax Species 0.000 description 2
• 229920002307 Dextran Polymers 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 241000710188 Encephalomyocarditis virus Species 0.000 description 2
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
• 229930182566 Gentamicin Natural products 0.000 description 2
• 108010015514 Glutamate-tRNA ligase Proteins 0.000 description 2
• 229920002527 Glycogen Polymers 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 101000768777 Haloferax lucentense (strain DSM 14919 / JCM 9276 / NCIMB 13854 / Aa 2.2) Uncharacterized 50.6 kDa protein in the 5'region of gyrA and gyrB Proteins 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 108090000604 Hydrolases Proteins 0.000 description 2
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
• 101000607404 Infectious laryngotracheitis virus (strain Thorne V882) Protein UL24 homolog Proteins 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 101000735632 Klebsiella pneumoniae Uncharacterized 8.8 kDa protein in aacA4 3'region Proteins 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 108010026217 Malate Dehydrogenase Proteins 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• 102100026126 Proline-tRNA ligase Human genes 0.000 description 2
• 239000012980 RPMI-1640 medium Substances 0.000 description 2
• 102000004191 Ribosomal protein L1 Human genes 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 241000710961 Semliki Forest virus Species 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 101000818100 Spirochaeta aurantia Uncharacterized 12.7 kDa protein in trpE 5'region Proteins 0.000 description 2
• 101001037658 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) Glucokinase Proteins 0.000 description 2
• 101001120268 Streptomyces griseus Protein Y Proteins 0.000 description 2
• 230000006044 T cell activation Effects 0.000 description 2
• 108091008874 T cell receptors Proteins 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 2
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 2
• 101710117021 Tyrosine-protein phosphatase YopH Proteins 0.000 description 2
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
• 238000002835 absorbance Methods 0.000 description 2
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
• 229910052782 aluminium Inorganic materials 0.000 description 2
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
• 102000005922 amidase Human genes 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
• 230000001588 bifunctional effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 210000004900 c-terminal fragment Anatomy 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 239000013553 cell monolayer Substances 0.000 description 2
• 238000001516 cell proliferation assay Methods 0.000 description 2
• 230000030570 cellular localization Effects 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 101150096566 clpX gene Proteins 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 235000017471 coenzyme Q10 Nutrition 0.000 description 2
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
• 238000012875 competitive assay Methods 0.000 description 2
• 239000003184 complementary RNA Substances 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 208000029078 coronary artery disease Diseases 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 230000009260 cross reactivity Effects 0.000 description 2
• YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
• 210000000172 cytosol Anatomy 0.000 description 2
• GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 108700004025 env Genes Proteins 0.000 description 2
• 101150030339 env gene Proteins 0.000 description 2
• 210000004700 fetal blood Anatomy 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 229960002518 gentamicin Drugs 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 229940096919 glycogen Drugs 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 150000004820 halides Chemical class 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 229940042743 immune sera Drugs 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 208000000509 infertility Diseases 0.000 description 2
• 230000036512 infertility Effects 0.000 description 2
• 231100000535 infertility Toxicity 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 239000004816 latex Substances 0.000 description 2
• 229920000126 latex Polymers 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
• 239000001095 magnesium carbonate Substances 0.000 description 2
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 101150019727 malQ gene Proteins 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 239000000693 micelle Substances 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000010172 mouse model Methods 0.000 description 2
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 229910052759 nickel Inorganic materials 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 101150101723 nrdA gene Proteins 0.000 description 2
• 239000007764 o/w emulsion Substances 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 238000004806 packaging method and process Methods 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 239000013600 plasmid vector Substances 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 101150037202 pmp20 gene Proteins 0.000 description 2
• 101150095517 pmpH gene Proteins 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 229920000136 polysorbate Polymers 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 239000004800 polyvinyl chloride Substances 0.000 description 2
• 229920000915 polyvinyl chloride Polymers 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 210000004986 primary T-cell Anatomy 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 101150079601 recA gene Proteins 0.000 description 2
• NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
• 238000004007 reversed phase HPLC Methods 0.000 description 2
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 210000000952 spleen Anatomy 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 229940104230 thymidine Drugs 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 239000011732 tocopherol Substances 0.000 description 2
• 229960001295 tocopherol Drugs 0.000 description 2
• 229930003799 tocopherol Natural products 0.000 description 2
• 235000010384 tocopherol Nutrition 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• 229910052722 tritium Inorganic materials 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 229940035936 ubiquinone Drugs 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 229940125575 vaccine candidate Drugs 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
• OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• DHBXNPKRAUYBTH-UHFFFAOYSA-N 1,1-ethanedithiol Chemical compound CC(S)S DHBXNPKRAUYBTH-UHFFFAOYSA-N 0.000 description 1
• NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
• AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
• IQFYYKKMVGJFEH-OFKYTIFKSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(tritiooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO[3H])O[C@H]1N1C(=O)NC(=O)C(C)=C1 IQFYYKKMVGJFEH-OFKYTIFKSA-N 0.000 description 1
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• 238000010600 3H thymidine incorporation assay Methods 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
• 108010066676 Abrin Proteins 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 241000024188 Andala Species 0.000 description 1
• 241000272478 Aquila Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 101100215646 Aspergillus parasiticus (strain ATCC 56775 / NRRL 5862 / SRRC 143 / SU-1) aflQ gene Proteins 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 241000714235 Avian retrovirus Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 238000011725 BALB/c mouse Methods 0.000 description 1
• 201000004569 Blindness Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 238000011740 C57BL/6 mouse Methods 0.000 description 1
• COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 102000009410 Chemokine receptor Human genes 0.000 description 1
• 108050000299 Chemokine receptor Proteins 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 108091029430 CpG site Proteins 0.000 description 1
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
• 108010054814 DNA Gyrase Proteins 0.000 description 1
• 108010041986 DNA Vaccines Proteins 0.000 description 1
• 239000003298 DNA probe Substances 0.000 description 1
• 229940021995 DNA vaccine Drugs 0.000 description 1
• 108010001625 Diaminopimelate epimerase Proteins 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 241000672609 Escherichia coli BL21 Species 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• 208000001860 Eye Infections Diseases 0.000 description 1
• 208000026351 Fallopian Tube disease Diseases 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 208000000666 Fowlpox Diseases 0.000 description 1
• 108700004714 Gelonium multiflorum GEL Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• CEXINUGNTZFNRY-BYPYZUCNSA-N Gly-Cys-Gly Chemical group [NH3+]CC(=O)N[C@@H](CS)C(=O)NCC([O-])=O CEXINUGNTZFNRY-BYPYZUCNSA-N 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
• 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 101150017040 I gene Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 102000000704 Interleukin-7 Human genes 0.000 description 1
• 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
• 125000000773 L-serino group Chemical group [H]OC(=O)[C@@]([H])(N([H])*)C([H])([H])O[H] 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 101100521429 Lactococcus lactis subsp. lactis (strain IL1403) prsA gene Proteins 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 208000007466 Male Infertility Diseases 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 108010031099 Mannose Receptor Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 102000016397 Methyltransferase Human genes 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• KTHDTJVBEPMMGL-VKHMYHEASA-N N-acetyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(C)=O KTHDTJVBEPMMGL-VKHMYHEASA-N 0.000 description 1
• KTHDTJVBEPMMGL-UHFFFAOYSA-N N-acetyl-L-alanine Natural products OC(=O)C(C)NC(C)=O KTHDTJVBEPMMGL-UHFFFAOYSA-N 0.000 description 1
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 101100278084 Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) dnaK1 gene Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 101710116435 Outer membrane protein Proteins 0.000 description 1
• 108010058846 Ovalbumin Proteins 0.000 description 1
• 241001503524 Ovine adenovirus Species 0.000 description 1
• 238000009004 PCR Kit Methods 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108010013639 Peptidoglycan Proteins 0.000 description 1
• 102000007456 Peroxiredoxin Human genes 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 description 1
• 101000762949 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Exotoxin A Proteins 0.000 description 1
• 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 description 1
• 102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108020005067 RNA Splice Sites Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 241001068263 Replication competent viruses Species 0.000 description 1
• 206010057190 Respiratory tract infections Diseases 0.000 description 1
• 101710137010 Retinol-binding protein 3 Proteins 0.000 description 1
• 102100038247 Retinol-binding protein 3 Human genes 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 108010039491 Ricin Proteins 0.000 description 1
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• 102000012479 Serine Proteases Human genes 0.000 description 1
• 108010022999 Serine Proteases Proteins 0.000 description 1
• 208000019802 Sexually transmitted disease Diseases 0.000 description 1
• 108010079723 Shiga Toxin Proteins 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 101100117145 Synechocystis sp. (strain PCC 6803 / Kazusa) dnaK2 gene Proteins 0.000 description 1
• 108010008038 Synthetic Vaccines Proteins 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 102400001102 Tail peptide Human genes 0.000 description 1
• 101800000868 Tail peptide Proteins 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 101100310092 Thauera selenatis serD gene Proteins 0.000 description 1
• 241000906446 Theraps Species 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 description 1
• FHICGHSMIPIAPL-HDYAAECPSA-N [2-[3-[6-[3-[(5R,6aS,6bR,12aR)-10-[6-[2-[2-[4,5-dihydroxy-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]ethoxy]ethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]peroxypropyl]-5-[[5-[8-[3,5-dihydroxy-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]octoxy]-3,4-dihydroxy-6-methyloxan-2-yl]methoxy]-3,4-dihydroxyoxan-2-yl]propoxymethyl]-5-hydroxy-3-[(6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoyl]oxy-6-methyloxan-4-yl] (2E,6S)-6-hydroxy-2-(hydroxymethyl)-6-methylocta-2,7-dienoate Chemical compound C=C[C@@](C)(O)CCC=C(C)C(=O)OC1C(OC(=O)C(\CO)=C\CC[C@](C)(O)C=C)C(O)C(C)OC1COCCCC1C(O)C(O)C(OCC2C(C(O)C(OCCCCCCCCC3C(C(OC4C(C(O)C(O)CO4)O)C(O)CO3)O)C(C)O2)O)C(CCCOOC(=O)C23C(CC(C)(C)CC2)C=2[C@@]([C@]4(C)CCC5C(C)(C)C(OC6C(C(O)C(O)C(CCOCCC7C(C(O)C(O)CO7)OC7C(C(O)C(O)CO7)O)O6)O)CC[C@]5(C)C4CC=2)(C)C[C@H]3O)O1 FHICGHSMIPIAPL-HDYAAECPSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 238000005903 acid hydrolysis reaction Methods 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 125000003172 aldehyde group Chemical group 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
• 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
• SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 229960003896 aminopterin Drugs 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 230000008350 antigen-specific antibody response Effects 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 239000000823 artificial membrane Substances 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 238000002820 assay format Methods 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 238000012832 cell culture technique Methods 0.000 description 1
• 230000007910 cell fusion Effects 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 210000000991 chicken egg Anatomy 0.000 description 1
• 208000028512 chlamydia infectious disease Diseases 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 101150043719 clpP1 gene Proteins 0.000 description 1
• 238000001246 colloidal dispersion Methods 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 230000001268 conjugating effect Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 230000000139 costimulatory effect Effects 0.000 description 1
• 239000003431 cross linking reagent Substances 0.000 description 1
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 210000001787 dendrite Anatomy 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 229960003699 evans blue Drugs 0.000 description 1
• 210000001808 exosome Anatomy 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000011152 fibreglass Substances 0.000 description 1
• 108700014844 flt3 ligand Proteins 0.000 description 1
• 210000003953 foreskin Anatomy 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 102000054766 genetic haplotypes Human genes 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 101150070420 gyrA gene Proteins 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 210000004754 hybrid cell Anatomy 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 210000004201 immune sera Anatomy 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 230000006054 immunological memory Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 208000037798 influenza B Diseases 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 238000007852 inverse PCR Methods 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 101150104734 ldh gene Proteins 0.000 description 1
• 101150026107 ldh1 gene Proteins 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
• FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 101150021603 metQ gene Proteins 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910044991 metal oxide Inorganic materials 0.000 description 1
• 150000004706 metal oxides Chemical class 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 238000002887 multiple sequence alignment Methods 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 230000000869 mutational effect Effects 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 238000011392 neighbor-joining method Methods 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 230000000269 nucleophilic effect Effects 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 101150028225 ordA gene Proteins 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 229940092253 ovalbumin Drugs 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 210000003200 peritoneal cavity Anatomy 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 150000004633 phorbol derivatives Chemical class 0.000 description 1
• 239000002644 phorbol ester Substances 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• 101150010607 pmpA gene Proteins 0.000 description 1
• 101150116202 pmpF gene Proteins 0.000 description 1
• 108700028325 pokeweed antiviral Proteins 0.000 description 1
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
• 229920002627 poly(phosphazenes) Polymers 0.000 description 1
• 229920000058 polyacrylate Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 150000003141 primary amines Chemical class 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
• 150000003248 quinolines Chemical class 0.000 description 1
• 230000000601 reactogenic effect Effects 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 229940124551 recombinant vaccine Drugs 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108010025552 ribosomal protein L11 Proteins 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 150000007949 saponins Chemical group 0.000 description 1
• 238000003345 scintillation counting Methods 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 238000011895 specific detection Methods 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000012289 standard assay Methods 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 238000012090 tissue culture technique Methods 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 206010044325 trachoma Diseases 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 210000001944 turbinate Anatomy 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 150000003668 tyrosines Chemical class 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 108700001624 vesicular stomatitis virus G Proteins 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• QAOHCFGKCWTBGC-QHOAOGIMSA-N wybutosine Chemical compound C1=NC=2C(=O)N3C(CC[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QAOHCFGKCWTBGC-QHOAOGIMSA-N 0.000 description 1
• QAOHCFGKCWTBGC-UHFFFAOYSA-N wybutosine Natural products C1=NC=2C(=O)N3C(CCC(NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O QAOHCFGKCWTBGC-UHFFFAOYSA-N 0.000 description 1
• 101150117012 yopN gene Proteins 0.000 description 1
• 239000011701 zinc Chemical class 0.000 description 1
• 229910052725 zinc Chemical class 0.000 description 1